Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas

Veterinary Journal

Volumn 200, Issue 3, 2014, Pages 387-392

  de la Fuente, Cristian ^a   Pumarola, Martí ^a   Blasco, Ester ^a   Fernández, Francisco ^a   Viu, Judit ^a   Añor, Sònia ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Astrocytoma; Coagulation; Fibrinolysis; Immunohistochemistry; Oligodendroglioma

Indexed keywords

D DIMER; FIBRIN; FIBRINOGEN; THROMBOPLASTIN; BIOLOGICAL MARKER; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CANCER GRADING; CONTROLLED STUDY; DISEASE ASSOCIATION; DOG DISEASE; FIBRINOLYSIS; GLIOBLASTOMA; GLIOMA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; OLIGODENDROGLIOMA; PROTEIN EXPRESSION; THROMBOSIS; TUMOR BIOPSY; TUMOR GROWTH; ANIMAL; DOG; DOG DISEASES; GENE EXPRESSION; GENETICS; METABOLISM; SPAIN; VETERINARY;

ANIMALS; ASTROCYTOMA; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; FIBRIN; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; GENE EXPRESSION; GLIOMA; IMMUNOHISTOCHEMISTRY; OLIGODENDROGLIOMA; SPAIN; THROMBOPLASTIN; THROMBOSIS;

EID: 84901003955     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2014.03.021     Document Type: Article

References (30)

1. Akassoglou K., Strickland S. Nervous system pathology: The fibrin perspective. Biological Chemistry 2002, 383:37-45.
2. Bardos H., Molnar P., Csecsei G., Adany R. Fibrin deposition in primary and metastatic human brain tumours. Blood Coagulation and Fibrinolysis 1996, 7:536-548.
3. Bootle-Wilbraham C.A., Tazzyman S., Thompson W.D., Stirk C.M., Lewis C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 2001, 4:269-275.
4. Callander N.S., Varki N., Vijaya Mohan Rao L. Immunohistochemical identification of tissue factor in solid tumors. Cancer 1992, 70:1194-1201.
5. Carretón E., González-Miguel J., Montoya-Alonso J.A., Morchón R., Simón F., Passeri B., Cantoni A.M., Kramer L. D-dimer deposits in lungs and kidneys suggest its use as a marker in the clinical workup of dogs with heartworm (Dirofilaria immitis) disease. Veterinary Parasitology 2013, 191:182-186.
6. Cotovio M., Monreal L., Navarro M., Segura D., Prada J., Alves A. Detection of fibrin deposits in horse tissues by immunohistochemistry. Journal of Veterinary Internal Medicine 2007, 21:1083-1089.
7. de la Fuente C., Monreal L., Cerón J., Pastor J., Viu J., Añor S. Fibrinolytic activity in cerebrospinal fluid of dogs with different neurological disorders. Journal of Veterinary Internal Medicine 2012, 26:1365-1373.
8. Dvorak H.F., Senger D.R., Dvorak A.M. Fibrin as a component of the tumor stroma: Origins and biological significance. Cancer Metastasis Reviews 1983, 2:41-73.
9. Eddleston M., de la Torre J.C., Oldstone M.B., Loskutoff D.J., Edgington T.S., Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system. A role for astrocytes in cerebral hemostasis. Journal of Clinical Investigation 1993, 92:349-358.
10. Golombiewski A., Gutberlet K., Rudolph R. Immunohistological assessment of fibrin deposition and thrombus formation in canine mammary neoplasia. Journal of Comparative Pathology 1997, 117:177-183.
11. Guan M., Jin J., Su B., Liu W.W., Lu Y. Tissue factor expression and angiogenesis in human glioma. Clinical Biochemistry 2002, 35:321-325.
12. Hamada K., Kuratsu J., Saitoh Y., Takeshima H., Nishi T., Ushio Y. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer 1996, 77:1877-1883.
13. Hjortoe G.M., Petersen L.C., Albrektsen T., Sorensen B.B., Norby P.L., Mandal S.K., Pendurthi U.R., Vijaya Mohan Rao L. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 2004, 103:3029-3037.
14. Langer F., Bokemeyer C. Crosstalk between cancer and haemostasis. Hämostaseologie 2012, 32:95-104.
15. Liu Y., Jiang P., Capkova K., Xue D., Ye L., Sinha S.C., Mackman N., Janda K.D., Liu C. Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Research 2011, 71:6492-6502.
16. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007, 114:97-109.
17. McEvoy F.J., Edgell T.A., Webbon P.M., Gaffney P.J. Detection of fibrin in canine neoplasia. British Veterinary Journal 1996, 152:83-91.
18. Mueller B.M., Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. The Journal of Clinical Investigation 1998, 101:1372-1378.
19. Platt S.R., Abramson C.J., Garosi L.S. Administering corticosteroids in neurologic diseases. Compendium on Continuing Education for the Practising Veterinarian 2005, 27:210-220.
20. Rossmeisl J.H., Duncan R.B., Huckle W.R., Troy G.C. Expression of vascular endothelial growth factor in tumors and plasma from dogs with primary intracranial neoplasms. American Journal of Veterinary Research 2007, 68:1239-1245.
21. Simpson-Haidaris P.J., Rybarczyk B. Tumors and fibrinogen. The role of fibrinogen as an extracellular matrix protein. Annals of the New York Academy of Sciences 2001, 936:406-425.
22. Staton C.A., Brown N.J., Lewis C.E. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opinion on Biological Therapy 2003, 3:1105-1120.
23. Stoica G., Levine J.M., Wolff J., Murphy K. Canine astrocytic tumors: A comparative review. Veterinary Pathology 2011, 48:266-275.
24. Stokol T., Daddona J.L., Mubayed L.S., Trimpert J., Kang S. Evaluation of tissue factor expression in canine tumor cells. American Journal of Veterinary Research 2011, 72:1097-1106.
25. Tehrani M., Friedman T.M., Olson J.J., Brat D.J. Intravascular thrombosis in central nervous system malignancies: A potential role in astrocytoma progression to glioblastoma. Brain Pathology 2008, 18:164-171.
26. Thaler J., Preusser M., Ay C., Kaider A., Marosi C., Zielinski C., Pabinger I., Hainfellner J.A. Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients. Thrombosis Research 2013, 131:162-165.
27. Versteeg H.H., Schaffner F., Kerver M., Petersen H.H., Ahamed J., Felding-Habermann B., Takada Y., Mueller B.M., Ruf W. Inhibition of tissue factor signaling suppresses tumor growth. Blood 2007, 111:190-199.
28. Wojtukiewicz M.Z., Sierko E., Klement P., Rak J. The hemostatic system and angiogenesis in malignancy. Neoplasia (New York, N.Y.) 2001, 3:371-384.
29. Yu J.L., May L., Lhotak V., Shahrzad S., Shirasawa S., Weitz J.I., Coomber B.L., Mackman N., Rak J.W. Oncogenic events regulate tissue factor expression in colorectal cancer cells: Implications for tumor progression and angiogenesis. Blood 2005, 105:1734-1741.
30. Zhang Y., Deng Y., Luther T., Müller M., Ziegler R., Waldherr R., Stern D.M., Nawroth P.P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. The Journal of Clinical Investigation 1994, 94:1320-1327.